Seaport Therapeutics

SPTX · Biotechnology

Verified executive transcripts, quotes, and interview insights from Seaport Therapeutics leadership.

2
Executives Tracked

About Seaport Therapeutics

Neuropsychiatric drug developer founded by PureTech, launched with a $100 million Series A. [BIOTECH-2026-10-04]

Access All Seaport Therapeutics Executive Data

Search transcripts, quotes, and verified statements from every Seaport Therapeutics executive via our platform or API.